Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 803 results for "fr ii"

Resumen: ERYTECH anuncia la inscripción del primer paciente e...

LYON, Francia--( BUSINESS WIRE )-- ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), la compañía francesa biofarmacéutica que desarrolla tratamientos innovadores de "inanición de tumores" para la leucemia aguda y ... Business Wire, 1 day ago

29 images for fr ii

Evanston Review, 1 day ago
CNET News, 7 hours ago
Register Pajaronian, 4 days ago
Manila Bulletin, 3 months ago
Manila Times, 2 months ago
St. Mary's College of California, 2 months ago
Catholic Herald, 3 months ago
Vatican Radio, 3 months ago
Clare Champion, 3 months ago
France24, 3 months ago

Toyota teaches tech at the track with the Scion FR-S

I hit the track in the 2014 Scion FR-S sports coupe to learn about the Toyota CAN-Gateway ECU tech. Antuan Goodwin/CNET The man who's responsible for one of the most exciting sport compact cars of this generation is a pretty reserved guy; at ...
 CNET News7 hours ago

Riassunto: ERYTECH annuncia la registrazione del primo paziente nello studio di fase II di ERY-ASP sul tumore al pancreas

LIONE, Francia--( BUSINESS WIRE )-- ERYTECH Pharma (Paris:ERYP) (Euronext Parigi: FR0011471135 - ERYP), la casa biofarmaceutica francese che sviluppa trattamenti innovativi, volti ad "affamare i tumori fino ad annientarli", per la ...
 Business Wire1 day ago Riassunto: ERYTECH rende noto l'arruolamento del primo paziente nello studio di Fase I/II con ERY-ASP nella leucemia linfoblastica acuta negli Stati Uniti  Business Wire1 week ago
Philippine Daily Inquirer

Over 18,000 Sona protesters march across the nation

Militant groups march towards the Batasang Pambansa during the president's State of the Nation Address. LEO SABANGAN II MANILA, Philippines—At least 18,000 protesters on Monday took to the streets in the Visayas in one of the biggest protests ...
 Philippine Daily Inquirer1 day ago

The Dispersion of Silver Iodide Particles from Ground-Based Generators over Complex Terrain. Part II: WRF Large-Eddy Simulations versus Observations [Journal of Applied Meteorology and Climatology]

(Journal of Applied Meteorology and Climatology Via Acquire Media NewsEdge) ABSTRACT A numerical modeling study has been conducted to explore the ability of the Weather Research and Forecasting (WRF) model-based large-eddy simulation (LES) with ...
 TMC Net1 week ago

Mangalore: Fr Ignatius DSouza Appointed New Bishop of Bareilly

Mangalore: Pope Francis on Friday 11th July 2014 appointed Fr Ignatius DSouza, Vicar General of the Diocese of Lucknow, as the new Bishop of Bareilly succeeding Bishop Anthony Fernandes whose resignation has been accepted. The appointment of the new ...
 Mangalorean2 weeks ago

Have to wait and watch for Modi's avatar II: Digvijay Singh

Days after his party colleague Shashi Tharoor observed that Prime Minister Narendra Modi was taking an avatar of modernity and progress, senior Congress leader Digvijay Singh today said it was too early to say any thing about him and one has to wait and watch ...
 Deccan Herald1 month ago

Queen Elizabeth II Unveils British Government Plan

Queen Elizabeth II unveiled the British government's legislative agenda Wednesday in a ceremony that combined a sumptuous display of pomp and power with a slim slate of bills on crime, pensions and fracking. The annual Queen's Speech is both a policy ...
 NDTV1 month ago

INNATE PHARMA : Completion of target enrollment in the phase II EffiKIR trial

Data on primary efficacy endpoint Leukemia-Free Survival expected end of 2015 MARSEILLE, France, July 24, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing ...
 Financial Content6 days ago Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial  BioSpace5 days ago Innate Pharma SA concludes target enrollment of 150 Acute Myeloid Leukemia patients in EffiKIR trial  Individual.com5 days ago

Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin(r) Peanut in Treatment of Peanut Allergy

Leading US centers in food allergy involved in an NIH-funded CoFAR6 study, co-chaired by Dr. Hugh Sampson and Dr. Stacie Jones NEW YORK and BAGNEUX, France, July 17, 2014 (GLOBE NEWSWIRE) -- DBV Technologies ( Euronext: DBV - ISIN: ...
 Minyanville1 week ago DBV TECHNOLOGIES : Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV's Viaskin® Peanut in Treatment of Peanut Allergy  4 Traders1 week ago DBV Technologies Completes last "food challenge" visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study  Reuters1 week ago DBV TECHNOLOGIES : Completes last "food challenge" visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less